多组学分析揭示移植性肾小球病存在T细胞主导的新亚类
该多中心研究纳入36例肾移植活检,其中14例为cg+MVI DSA-/C4d-、22例为CA-AMR DSA+/C4d+,采用NanoString B-HOT转录组面板及5标记多重免疫荧光分析。
要点
- cg+MVI DSA-/C4d-活检不满足CA-AMR诊断标准,但具有显著T细胞浸润与活性。
- CA-AMR DSA+/C4d+样本以NK细胞、巨噬细胞及补体相关基因表达增高为特征。
- 多组学技术可识别移植性肾小球病的T细胞主导新亚类,可能影响未来分类。
核心结论
- cg+MVI DSA-/C4d-的肾移植活检呈现突出的T细胞存在与活性,可能代表一种更偏T细胞主导的表型。
研究设计与样本
- 多中心跨洲研究纳入36例肾移植活检,比较14例cg+MVI DSA-/C4d-与22例CA-AMR DSA+/C4d+的免疫组与转录组图谱。
- 采用NanoString Banff-Human Organ Transplant(B-HOT)面板进行转录组分析,并用两个创新的5标记多重免疫荧光面板进行正交子集分析。
主要发现
- CA-AMR DSA+/C4d+样本肾小球NK细胞丰度更高,巨噬细胞转录组细胞类型评分更高,补体相关基因(如C5AR1)表达增加,血管生成、间质纤维化肾小管萎缩、CA-AMR及DSA相关通路活性更高。
- cg+MVI DSA-/C4d-样本肾小球T细胞(CD3+、CD3+CD8+及CD3+CD8-)丰度与活性更高。
临床怎么用
- 对cg+MVI DSA-/C4d-的移植肾活检,应关注T细胞介导的免疫活动,而非仅按抗体介导排斥评估。
- 多组学技术有助于识别移植性肾小球病的T细胞主导亚类,可能为个体化免疫抑制提供依据。
局限性
- 研究样本量较小(共36例,其中cg+MVI DSA-/C4d-仅14例)。
- 原文未报告长期临床结局与治疗反应数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney transplant (KTx) biopsies showing transplant glomerulopathy (TG) (glomerular basement membrane double contours (cg) > 0) and microvascular inflammation (MVI) in the absence of C4d staining and donor-specific antibodies (DSAs) do not fulfill the criteria for chronic active antibody-mediated rejection (CA-AMR) diagnosis and do not fit into any other Banff category. To investigate this, we initiated a multicenter intercontinental study encompassing 36 cases, comparing the immunomic and transcriptomic profiles of 14 KTx biopsies classified as cg+MVI DSA-/C4d- with 22 classified as CA-AMR DSA+/C4d+ through novel transcriptomic analysis using the NanoString Banff-Human Organ Transplant (B-HOT) panel and subsequent orthogonal subset analysis using two innovative 5-marker multiplex immunofluorescent panels. Nineteen genes were differentially expressed between the two study groups. Samples diagnosed with CA-AMR DSA+/C4d+ showed a higher glomerular abundance of natural killer cells and higher transcriptomic cell type scores for macrophages in an environment characterized by increased expression of complement-related genes (i.e., C5AR1) and higher activity of angiogenesis, interstitial fibrosis tubular atrophy, CA-AMR, and DSA-related pathways when compared to samples diagnosed with cg+MVI DSA-/C4d-. Samples diagnosed with cg+MVI DSA-/C4d- displayed a higher glomerular abundance and activity of T cells (CD3+, CD3+CD8+, and CD3+CD8-). Thus, we show that using novel multiomic techniques, KTx biopsies with cg+MVI DSA-/C4d- have a prominent T-cell presence and activity, putting forward the possibility that these represent a more T-cell dominant phenotype.
引用
- Cristoferi I, Varol H, van Baardwijk M, et al. Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass. Kidney Int. 2023. PMID: 38128610. doi:10.1016/j.kint.2023.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。